Cipla receives final approval for generic version of Impax Laboratories, Albenza
It is an anthelmintic drug indicated for use in treatment of parenchymal neurocysticercosis
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Biocon and Mylan announce positive CHMP opinion for Fulphila, Biosimilar Pegfilgrastim
Fulphila was approved by the US FDA earlier this year and is the first FDA-approved biosimilar for Neulasta in the US
Centaur Pharma concludes 10th common cold awareness week campaign
Centaur has been undertaking the 'Common Cold Awareness Week' campaign to prevent people from self medication and encourage them…
Sun Pharma gets Australia TGA nod for plaque psoriasis treatment drug
Sun Pharma is to launch a patient support programme to assist patients prescribed with this drug
Schott Kaisha hosts pharma packaging stalwarts at its Jambusar plant, Gujarat
More than 60 delegates took part in the half-day visit to Schott Kaisha’s state-of-the-art facility
GSK grabs new drug development head from Boehringer
GlaxoSmithKline has hired Chris Corsico from German drugmaker Boehringer Ingelheim
AstraZeneca plots China robot offensive to counter price cuts
With smart cancer diagnostics and AI systems to improve ambulance pick-ups for patients with chest pain, AstraZeneca aims to move…
‘On the right track for the future’
What are the developments that set the trend for pharmaceutical filling and packaging machines? Gerhard Breu, Chairman, Optima…
Changes during aging in elderly persons
Dr Samir Mashelkar, Consultant-Life Science, Pharma,Biotech, discusses the damage caused by free radicals and how several heart…
Plasticell wins military contract to develop regenerative medicines for the battlefield
Both trials are testing Xtandi in men with hormone-sensitive prostate cancer